INSMED INC Repayments of Debt
INSMED INC (INSM) reported Repayments of Debt of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2021-02-25
- INSMED INC repayments of debt for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- INSMED INC repayments of debt for the quarter ending 2019-09-30 was $0.00.
- INSMED INC repayments of debt for the quarter ending 2019-06-30 was $0.00.
- INSMED INC repayments of debt for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- INSMED INC repayments of debt for fiscal 2020 was $0.00.
- INSMED INC repayments of debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- INSMED INC repayments of debt for fiscal 2018 was $57.84M.
- INSMED INC repayments of debt for fiscal 2017 was $0.00.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month | Repayments of Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | $2.83M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $2.83M derived: sum of 3 quarters · filed 2021-02-25 | $2.83M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | $2.83M derived: sum of 2 quarters · filed 2021-02-25 | $2.83M derived: sum of 3 quarters · filed 2021-02-25 | $2.83M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.83M derived: sum of 2 quarters · filed 2021-02-25 | $2.83M derived: sum of 3 quarters · filed 2021-02-25 | $57.84M 10-K · filed 2021-02-25 | $55.00M 10-K · filed 2019-02-22 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $55.00M 10-Q · filed 2019-10-30 | $55.00M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $55.00M 10-Q · filed 2019-08-01 | $55.00M derived: sum of 3 quarters · filed 2020-02-25 | $55.00M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $55.00M 10-Q · filed 2019-05-07 | $55.00M derived: sum of 2 quarters · filed 2020-02-25 | $55.00M derived: sum of 3 quarters · filed 2020-02-25 | $55.00M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $0.00 derived: sum of 2 quarters · filed 2018-10-30 | $0.00 10-Q · filed 2018-10-30 | ||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-02 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |